The FDA has approved Lysteda (tranexamic acid tablets, from Xanodyne), a non-hormonal treatment for women suffering from menorrhagia, cyclic heavy menstrual bleeding (HMB). This approval was based on clinical trial data that demonstrated a statistically significant reduction in menstrual blood loss in women who received Lysteda, compared with those taking placebo.

For more information call (908) 604-2354 or visit